- Poster presentation
- Open Access
The association between bone age advancement and insulin in prepubertal children with obesity
International Journal of Pediatric Endocrinology volume 2015, Article number: P71 (2015)
Obesity is associated with bone age (BA) advancement of unclear etiology. In animal study, insulin may directly modulate skeletal growth. Our objective was to investigate the association with BA maturation and insulin levels in children with overweight and obesity.
In this cross-sectional study of 103 prepubertal children, anthropometric data and hormonal values during oral glucose tolerance test were measured. Subjects were divided into two groups by the difference between BA and chronological age (CA) (noted as BA-CA).
The study population included 49 (47.6%) males and 54 (52.4%) females with a mean age of 7.6 ± 1.6 years. The advanced bone age group defined as BA-CA>1 year (n=53) had significantly higher HOMA-IR, fasting insulin levels and lower quantitative insulin sensitivity check index (QUICKI). Also, BA-CA was significantly correlated with fasting insulin (r=0.315, P<0.001), HOMA-IR (r=0.288, P<0.001), and QUICKI (r=-0.353, P<0.001). In multiple regression analysis, fasting insulin was identified as significant independent predictors for BA-CA.
Skeletal age is more advanced in overweight and obese children with hyperinsulinemia and insulin resistance. These findings suggest that insulin may modulate skeletal growth.
About this article
Cite this article
Lee, H.S., Jeong, H.R., Kwon, E. et al. The association between bone age advancement and insulin in prepubertal children with obesity. Int J Pediatr Endocrinol 2015, P71 (2015). https://doi.org/10.1186/1687-9856-2015-S1-P71
- Insulin Level
- Oral Glucose Tolerance Test
- Obese Child
- Fasting Insulin